Laboratory medicine as the science that underpins medicine: The "high-sensitivity" troponin paradigm

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 5, 2015, Pages 653-664

  Ferraro, Simona ^a   Panteghini, Mauro ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

acute myocardial infarction; assay performance; prognosis; sensitivity; troponin

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; TROPONIN; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ALGORITHM; ASSAY; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL LABORATORY; CLINICAL MEDICINE; COST EFFECTIVENESS ANALYSIS; DEATH; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; EMERGENCY MEDICINE; EMERGENCY PHYSICIAN; EMERGENCY WARD; FALSE POSITIVE RESULT; GERIATRIC PATIENT; HIGH RISK PATIENT; HUMAN; LABORATORY TEST; MULTICENTER STUDY (TOPIC); NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT MONITORING; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; PROGNOSTIC ASSESSMENT; RECEIVER OPERATING CHARACTERISTIC; REVIEW; RISK FACTOR; SCIENCE; SENSITIVITY AND SPECIFICITY; CLINICAL CHEMISTRY; CORONARY ARTERY DISEASE; HEART MUSCLE; LIMIT OF DETECTION; METABOLISM; PROCEDURES; REFERENCE VALUE; STANDARDS;

CLINICAL CHEMISTRY TESTS; CORONARY ARTERY DISEASE; HUMANS; LIMIT OF DETECTION; MYOCARDIUM; REFERENCE VALUES; TROPONIN;

EID: 84928015786     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0812     Document Type: Review

References (75)

1. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined. A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000;36:959-69.
2. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 2007;116:2634-53.
3. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012;60:1581-98.
4. Omland T. Sensitive cardiac troponin assays: sense and sensibility. Eur Heart J 2012;33:944-6.
5. Wu AH, Bolger AF, Hollander JE. Growing pains with the use of high-sensitivity cardiac troponin assays. J Am Coll Cardiol 2013;62:1250-1.
6. Jesse RL. On the relative value of an assay versus that of a test. A history of troponin for the diagnosis of myocardial infarction. J Am Coll Cardiol 2010;55:2025-8.
7. Katus HA, Giannitsis E, Jaffe AS, Thygesen K. Higher sensitivity troponin assays: quo vadis? Eur Heart J 2009;30:127-8.
8. Hollander JE. Highly sensitive troponins. The answer or just more questions? J Am Coll Cardiol 2009;54:1173-5.
9. de Lemos JA, Morrow DA, deFilippi CR. Highly sensitive troponin assays and the cardiology community: a love/hate relationship? Clin Chem 2011;57:826-9.
10. Daniels LB. The enemy of good? Making the most of highly sensitive troponin assays. J Am Coll Cardiol 2013;61:1914-6.
11. Kramer CM. Avoiding the imminent plague of troponinitis. The need for reference limits for high-sensitivity cardiac troponin T. J Am Coll Cardiol 2014;63:1449-50.
12. th percentile limit for cardiac troponins. Clin Chem Lab Med 2009;47:1179-82.
13. th percentile reference values for 3 2nd-generation assays. Clin Chem 2007;53:1558-60.
14. Hall AS, Barth JH. Universal definition of myocardial infarction. Heart 2009;95:247-9.
15. Panteghini M. Quality requirements for troponin assays - an overview. In: Troponin monograph 2012. Alexandria, NSW: Australasian Association of Clinical Biochemists, 2012:53-61.
16. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004;50:327-32.
17. Tate JR. Troponin revisited 2008: assay performance. Clin Chem Lab Med 2008;46:1489-500.
18. Panteghini M. Assay-related issues in the measurement of cardiac troponins. Clin Chim Acta 2009;402:88-93.
19. Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007;116:1242-9.
20. Jarausch J, Braun S, Dolci A, Jaffe A, Mühlbacher A, Olven C, et al. Evaluation of a development version of the Elecsys® high sensitive troponin T assay. Clin Chem 2008;54(Suppl):A91.
21. Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta 2011;412:748-54.
22. Clinical and Laboratory Standards Institute. Protocols for determination of limits of detection and limits of quantitation; Approved guideline. CLSI document EP17-A, 2004.
23. Tate JR, Panteghini M, Koerbin G, Hickman PE, Schneider HG, Jaffe AS. Verification of the analytical characteristics of troponin assays in the laboratory - a how to guide. In: Troponin monograph 2012. Alexandria, NSW: Australasian Association of Clinical Biochemists, 2012:69-85.
24. UKNEQAS External Quality Assessment for Cardiac Markers in Medical Practice. Available from: http://www.ukneqas-cm.org.uk/. Accessed August 2014.
25. Melanson SE, Conrad MJ, Mosammaparast N, Jarolim P. Implementation of a highly sensitive cardiac troponin I assay: test volumes, positivity rates and interpretation of results. Clin Chem Acta 2008;395:57-61.
26. th International Symposium on Cardiac Biomarkers, August 2011, Paris, France.
27. Dolci A, Braga F, Valente C, Guzzetti S, Panteghini M. Impact of implementation of the high-sensitivity cardiac troponin T assay in a university hospital setting. Clin Chem 2011;57:1211-2.
28. Braga F, Dolci A, Valente C, Boido A, Moretti A, Guzzetti S, et al. Impact of the implementation of highly sensitive cardiac troponin T assay in a university hospital setting. Biochim Clin 2011;35:301-6.
29. Dolci A, Panteghini M. The exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more. Clin Chim Acta 2006;369:179-87.
30. Collinson PO, Stubbs PJ. Are troponins confusing? Heart 2003;89:1285-7.
31. Mendis S, Thygesen K, Kuulasmaa K, Giampaoli S, Mahonen M, Blackett KN, et al. World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol 2011;40:139-46.
32. Braunwald E, Morrow DA. Unstable angina is it time for a requiem? Circulation 2013;127:2452-7.
33. Morrow DA. Clinical application of sensitive troponin assays. N Engl J Med 2009;361:913-5.
34. Wu AH, Jaffe AS. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. Am Heart J 2008;155:208-14.
35. Cullen L, Jaffe AS. The clinical evidence for 'delta troponin' use. In: Troponin monograph 2012. Alexandria, NSW: Australasian Association of Clinical Biochemists, 2012:45-52.
36. Wu AH, Lu QA, Todd J, Moecks J, Wians F. Short- and long-term biological variation in cardiac troponin I measured with a highsensitivity assay: implications for clinical practice. Clin Chem 2009;55:52-8.
37. Vasile VC, Saenger AK, Kroning JM, Jaffe AS. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:1086-90.
38. Frankenstein L, Wu AH, Hallermayer K, Wians FH, Giannitsis E, Katus HA. Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. Clin Chem 2011;57:1068-71.
39. De Lemos JA. Increasingly sensitive assays for cardiac troponins. A review. JAMA 2013;309:2262-9.
40. Supak Smolcic V, Drvar V, Hrabric Vlah S, Bilic-Zulle L. The issue of rational ordering of high sensitive cardiac troponin T test in outpatients' emergency room. Clin Chem Lab Med 2014;52:S1142.
41. Wu AH. Interpretation of high sensitivity cardiac troponin I results: reference to biological variability in patients who present to the emergency room with chest pain: case report series. Clin Chim Acta 2009;401:170-4.
42. Dolci A, Braga F, Valente C, Boido A, Moretti A, Guzzetti S, et al. Impact of the highly sensitive cardiac troponin (hsTnT) assay on the triage of emergency department (ED) patients. Clin Chem Lab Med 2011;49:S292.
43. Meune C, Reichlin T, Irfan A, Schaub N, Twerenbold R, Meissner J, et al. How safe is the outpatient management of patients with acute chest pain and mildly increased cardiac troponin concentrations? Clin Chem 2012;58:916-28.
44. Galvani M, Panteghini M, Ottani F, Cappelletti P, Chiarella F, Chiariello M, et al. The new definition of myocardial infarction: analysis of the ESC/ACC consensus document and reflections on its applicability to the Italian Health System. Ital Heart J 2002;3:543-57.
45. Casagranda I, Cavazza M, Clerico A, Galvani M, Ottani F, Zaninotto M, et al. Proposal for the use in emergency departments of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistent ST-segment elevation. Clin Chem Lab Med 2013;51:1727-37.
46. Reiter M, Twerenbold R, Reichlin T, Haaf P, Peter F, Meissner J, et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J 2011;32:1379-89.
47. Than M, Cullen L. The challenges of sensitive and highly sensitive troponin assay use in the emergency department - the emergency physician's perspective. In: Troponin monograph 2012. Alexandria, NSW: Australasian Association of Clinical Biochemists, 2012:27-32.
48. Body R, Carley S, McDowell G, Jaffe AS, France M, Cruickshank K, et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol 2011;58:1332-9.
49. th International Symposium on Cardiac Biomarkers, August 2011, Paris, France.
50. Reichlin T, Schindler C, Drexler B, Twerenbold R, Reiter M, Zellweger C, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. JAMA 2012;172:1211-8.
51. Mueller M, Biener M, Vafaie M, Doerr S, Keller T, Blankenberg S, et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem 2012;58:209-18.
52. Braga F, Dolci A, Cavallero A, Ghezzi A, Infusino I, Milano M, et al. Evaluation of the sensitivity of two highly sensitive troponin assays for early detection of non ST-elevation myocardial infarction (NSTEMI). Biochim Clin 2011;35:186-9.
53. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
54. Thokala P, Goodacre SW, O Collinson PO, Stevens JW, Mills NL, Newby DE, et al. Cost-effectiveness of presentation versus delayed troponin testing for acute myocardial infarction. Heart 2012;98:1498-503.
55. Mills NL, Churchhouse AM, Lee KK, Anand A, Gamble D, Shah AS, et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011:305;1210-6.
56. Filippatos G, Farmakis D, Parissis J. Novel biomarkers in acute coronary syndromes. New molecules, new concepts, but what about new treatment strategies? J Am Coll Cardiol 2014;63:1654-6.
57. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bitt JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011;58:2550-83.
58. Panteghini M. The new definition of myocardial infarction and the impact of troponin determination on clinical practice. Int J Cardiol 2006;106:298-306.
59. Valgimigli M, Leonardi S. Peri-procedural myocardial infarction and troponism: a quick journey through the land of confusion. Heart 2012;98:1400-1.
60. White HD, Thygesen K, Alpert JS, Jaffe AS. Ischaemic heart disease. Clinical implications of the Third Universal Definition of Myocardial Infarction. Heart 2014;100:424-32.
61. Masoudi FA, Ponirakis A, Yeh RW, Maddox TM, Beachy J, Casale PN, et al. Cardiovascular Care Facts. A report from the National Cardiovascular Data Registry: 2011. J Am Coll Cardiol 2013;62:1931-47.
62. Saleh N, Svane B, Hansson LO, Jensen J, Nilsson T, Danielsson O, et al. Response of serum C reactive protein to percutaneous coronary intervention has prognostic value. Clin Chem 2005;51:2124-30.
63. Moussa ID1, Klein LW, Shah B, Mehran R, Mack MJ, Brilakis ES, et al. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). J Am Coll Cardiol 2013;62:1563-70.
64. Panteghini M. Cardiac marker testing following surgery. Ann Clin Biochem 2001;38:287-8.
65. Boersma E, Kertai MD, Schouten O, Bax JJ, Noordzij P, Steyerberg EW, et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 2005;118:1134-41.
66. Landesberg G, Beattie WS, Mosseri M, Jaffe AS, Alpert JS. Perioperative myocardial infarction. Circulation 2009;119:2936-44.
67. Bursi F, Babuin L, Barbieri A, Politi L, Zennaro M, Grimaldi T, et al. Vascular surgery patients: perioperative and long-term risk according to the ACC/AHA guidelines, the additive role of postoperative troponin elevation. Eur Heart J 2005;26:2448-56.
68. Alcock RF, Kouzios D, Naoum C, Hillis GS, Brieger BD. Perioperative myocardial necrosis in patients at high cardiovascular risk undergoing elective non-cardiac surgery. Heart 2012;98:792-8.
69. Weber M, Luchner A, Manfred S, Mueller C, Liebetrau C, Schlitt A, et al. Incremental value of high-sensitive troponin T in addition to the revised cardiac index for perioperative risk stratification in non-cardiac surgery. Eur Heart J 2013;34:853-62.
70. Wijns W, Crea F. Elevated troponin in stable coronary artery disease: the sound of silence. Heart 2011;97:785-6.
71. Koenig W, Breitling LP, Hahmann H, Wusten B, Brenner H, Rothenbacher D. Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up. Clin Chem 2012;58:1215-24.
72. McQueen MJ, Kavsak PA, Xu L, Shestakovska O, Yusuf S. Predicting myocardial infarction and other serious cardiac outcomes using high-sensitivity cardiac troponin T in a high-risk stable population. Clin Biochem 2013;46:5-9.
73. Korosoglou G, Lehrke S, Mueller D, Hosch W, Kauczor HU, Humpert PM, et al. Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. Heart 2011;97:823-31.
74. Lee KK, Shah AS, Mills NL. Diagnosis of myocardial infarction: cardiac troponin I or troponin T? Clin Biochem 2014;47: 319-20.
75. Costa FM, Ferreira J, Aguiar C, Dores H, Figueira J, Mendes M. Impact of ESC/ACCF/AHA/WHF universal definition of myocardial infarction on mortality at 10 years. Eur Heart J 2012;33:2544-50.